Grimes & Company’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,768
| Closed | -$88.8K | – | 325 |
|
|
2023
Q1 | $88.8K | Buy |
9,768
+89
| +0.9% | +$809 | ﹤0.01% | 285 |
|
|
2022
Q4 | $114K | Buy |
9,679
+49
| +0.5% | +$575 | ﹤0.01% | 277 |
|
|
2022
Q3 | $204K | Buy |
9,630
+116
| +1% | +$2.46K | 0.01% | 253 |
|
|
2022
Q2 | $231K | Buy |
9,514
+145
| +2% | +$3.52K | 0.01% | 247 |
|
|
2022
Q1 | $467K | Buy |
9,369
+1,537
| +20% | +$76.6K | 0.02% | 204 |
|
|
2021
Q4 | $550K | Sell |
7,832
-767
| -9% | -$53.9K | 0.03% | 195 |
|
|
2021
Q3 | $802K | Buy |
8,599
+543
| +7% | +$50.6K | 0.03% | 169 |
|
|
2021
Q2 | $810K | Buy |
8,056
+560
| +7% | +$56.3K | 0.04% | 166 |
|
|
2021
Q1 | $699K | Buy |
7,496
+2,799
| +60% | +$261K | 0.03% | 169 |
|
|
2020
Q4 | $388K | Buy |
4,697
+121
| +3% | +$10K | 0.02% | 202 |
|
|
2020
Q3 | $393K | Buy |
4,576
+22
| +0.5% | +$1.89K | 0.03% | 190 |
|
|
2020
Q2 | $424K | Buy |
4,554
+1,183
| +35% | +$110K | 0.03% | 185 |
|
|
2020
Q1 | $96K | Buy |
3,371
+714
| +27% | +$20.3K | 0.01% | 221 |
|
|
2019
Q4 | $110K | Buy |
+2,657
| New | +$110K | 0.01% | 259 |
|